Activation of phospholipase C/Ca^<2+> system in thyroid cells and its physiological and pathological roles.
甲状腺细胞磷脂酶C/Ca^2系统的激活及其生理病理作用。
基本信息
- 批准号:07457217
- 负责人:
- 金额:$ 4.16万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have recently found that adenosine inhibits TSH-induced activation of adenylyl cyclase/cAMP system and enhances TSH-induced activation of phospholipase C/Ca^<2+> system in rat thyroid cells. In thyroid cells, in addition to norepinephrine, acetylcholine and ATP,lysosphingolipids such as sphingosine 1-phosphate (SlP) and sphingosylsphosphorylcholine (SPC) has also been suggested to be a potent Ca^<2+> mobilizer. In this study, we planned to clarify the roles of phospholipase C/Ca^<2+> system in thyroid cells. We obtained the following novel findings. (1) In human thyroid cells as well, it was demonstrated that phospholipase C/Ca^<2+> system was regulated through the cross-talk of TSH and adenosine. (2) To clarify the cross-talk mechanism by which TSH and adenosine regulate phospholipase C activity, we used in vivo Cos-7 cell reconstitution system, in which cDNAs encoding receptors, each wild type G-protein subunit and mutant subunit. We found that adenosine-induced modification of two TSH-induced responses were mediated by a single type of Gi protein, Gi2 or Gi3 ; alpha subunit mediates inhibition of AC and betagamma subunits activation of phospholipase C.(3) Grave's IgG in the presence of adenosine induced activation of phospholipase C/Ca^<2+> system, and hence it was suggested that the measurement of phospholipase C/Ca^<2+> system is applied for a novel diagnosis of Grave's disease. (4) SlP and SPC regulated phospholipase C/Ca^<2+> system, H_2O_2 generation, cell proliferation and so on in thyroid cells. Thus, these lipid mediators were suggested to be novel agonists in these cells.
我们最近发现腺苷抑制tsh诱导的大鼠甲状腺细胞腺苷酸环化酶/cAMP系统的激活,并增强tsh诱导的磷脂酶C/Ca^<2+>系统的激活。在甲状腺细胞中,除去甲肾上腺素、乙酰胆碱和ATP外,溶解鞘脂如鞘磷脂1-磷酸(SlP)和鞘磷脂(SPC)也被认为是一种有效的Ca^<2+>动员剂。在本研究中,我们计划阐明磷脂酶C/Ca^<2+>系统在甲状腺细胞中的作用。我们获得了以下新发现。(1)在人甲状腺细胞中,也证实了磷脂酶C/Ca^<2+>系统是通过TSH和腺苷的串扰调节的。(2)为了明确TSH和腺苷调节磷脂酶C活性的串扰机制,我们利用体内Cos-7细胞重构系统,其中cdna编码受体,每种野生型g蛋白亚基和突变亚基。我们发现腺苷诱导的两种tsh诱导反应的修饰是由单一类型的Gi蛋白介导的,Gi2或Gi3;α亚基介导AC和β - γ亚基对磷脂酶C活化的抑制。(3)腺苷存在下Grave's IgG诱导磷脂酶C/Ca^<2+>系统活化,因此建议测定磷脂酶C/Ca^<2+>系统可用于graves病的新诊断。(4) SlP和SPC调节甲状腺细胞磷脂酶C/Ca^<2+>系统、H_2O_2生成、细胞增殖等。因此,这些脂质介质被认为是这些细胞中的新型激动剂。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fumikazu Okajima: "Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids." J.B
Fumikazu Okajima:“百日咳毒素抑制 HL60 白血病细胞中磷脂酶 C 的激活以及鞘氨醇磷酸胆碱和半乳糖鞘氨醇对 Ca2+ 的动员。GTP 结合蛋白偶联受体对溶血鞘脂的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fumikazu Okajima: "Sphingosine 1-phosphate stimulate hydrogen peroxide generation through activation of phospholipase C-Ca2+ system in FRTL-5 thyroid cells : possible involvement of GTP-binding proteins the lipid singaling." Endocrinology. 138. 220-229 (1
Fumikazu Okajima:“1-磷酸鞘氨醇通过激活 FRTL-5 甲状腺细胞中的磷脂酶 C-Ca2 系统来刺激过氧化氢的产生:GTP 结合蛋白可能参与脂质信号传导。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Dong-Soon Im: "Chracterization of sphingosine 1-phosphate-induced actions and its signaling pathways in rat hepatocytes." Am.J.Physiol.(in press). (1997)
Dong-Soon Im:“大鼠肝细胞中 1-磷酸鞘氨醇诱导作用及其信号通路的表征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Kimura: "Thyrotropin-induced hydrogen peroxide production in FRTL-5 thyroid cells is mediated not by adenosine 3',5'-monophosphate,but by Ca2+ signaling followed by phospholipase A2 activation and potentiated by an adenosine derivative." Endocrinology.
T.Kimura:“FRTL-5 甲状腺细胞中促甲状腺素诱导的过氧化氢产生不是由 3,5-单磷酸腺苷介导的,而是由 Ca2 信号传导、随后磷脂酶 A2 激活并由腺苷衍生物增强的。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yanagita,Y.: "An adenosine derivative cooperates with TSH and Graves'IgG to induceCa2+ mobilization in single human thyroid cells." Mol.Cell.Endorinol.118. 47-56 (1996)
Yanagita,Y.:“腺苷衍生物与 TSH 和 GravesIgG 协同作用,诱导单个人类甲状腺细胞中的 Ca2 动员。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKAJIMA Fumikazu其他文献
OKAJIMA Fumikazu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKAJIMA Fumikazu', 18)}}的其他基金
Are proton-sensing receptors working in ischemia~analysis with receptor-deficient mice
质子敏感受体在缺血中起作用吗〜受体缺陷小鼠的分析
- 批准号:
25670617 - 财政年份:2013
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Role of host proton-sensing receptors in tumorigenesis: analysis with receptor-deficient mice
宿主质子敏感受体在肿瘤发生中的作用:受体缺陷小鼠的分析
- 批准号:
23659029 - 财政年份:2011
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Novel roles of lysolipid receptors : proton sensing and its biological function
溶血脂受体的新作用:质子传感及其生物学功能
- 批准号:
21390016 - 财政年份:2009
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Novel roles of lysolipid receptors as mediators of lipoprotein actions and proton sensors
溶血脂受体作为脂蛋白作用介质和质子传感器的新作用
- 批准号:
19390015 - 财政年份:2007
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of distribution of extracellular Edg receptor family ligands and their physiological roles
细胞外Edg受体家族配体分布的调控及其生理作用
- 批准号:
15370051 - 财政年份:2003
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of extracellular S1P concentration and mechanisms of the lipid receptor subtype-specific actions
细胞外 S1P 浓度的调节和脂质受体亚型特异性作用的机制
- 批准号:
12480185 - 财政年份:2000
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Association between thyrotropin (TSH) levels and cancer recurrence among patients with well differentiated thyroid cancer: A retrospective cohort study
高分化甲状腺癌患者促甲状腺素 (TSH) 水平与癌症复发之间的关联:一项回顾性队列研究
- 批准号:
441105 - 财政年份:2020
- 资助金额:
$ 4.16万 - 项目类别:
Fellowship Programs
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss
促甲状腺素受体、促甲状腺素与骨丢失机制
- 批准号:
10182095 - 财政年份:2017
- 资助金额:
$ 4.16万 - 项目类别:
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss
促甲状腺素受体、促甲状腺素与骨丢失机制
- 批准号:
9317142 - 财政年份:2017
- 资助金额:
$ 4.16万 - 项目类别:
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone Loss
促甲状腺素受体、促甲状腺素与骨丢失机制
- 批准号:
9906208 - 财政年份:2017
- 资助金额:
$ 4.16万 - 项目类别:
Importance of Thyrotropin-releasing hormone of hypothalamic paraventricular nucleus for the hypothalamic-pituitary-thyroid axis and the leptin-induced thyroid hormone regulation in mice
下丘脑室旁核促甲状腺激素释放激素对下丘脑-垂体-甲状腺轴的重要性以及瘦素诱导的小鼠甲状腺激素调节
- 批准号:
17K09872 - 财政年份:2017
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
GATA2 Mediates the Negative Regulation of the Prepro-Thyrotropin-Releasing Hormone Gene by Liganded T3 Receptor beta2 in the Paraventricular Nucleus of the Hypothalamus.
GATA2 通过下丘脑室旁核配体 T3 受体 beta2 介导前促甲状腺素释放激素基因的负调节。
- 批准号:
15K09425 - 财政年份:2015
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The molecular mechanism of the linear-log relation between thyrotropin synthesis and T3
促甲状腺素合成与T3线性对数关系的分子机制
- 批准号:
24590689 - 财政年份:2012
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Untersuchung eines erweiterten Interaktionsspektrums des Thyrotropin Rezeptors
促甲状腺素受体的扩展相互作用谱的研究
- 批准号:
162103536 - 财政年份:2010
- 资助金额:
$ 4.16万 - 项目类别:
Research Grants
New TSHR Antagonists as a potential approach to bridge the therapeutic gap of Graves' ophthalmopathy as follow up to' Modulators fort he Thyrotropin receptor: Molekular mechansims allosteric binding and mode of action of small molecules'
新的 TSHR 拮抗剂作为弥补格雷夫斯眼病治疗差距的潜在方法,作为“促甲状腺激素受体调节剂:分子机制模拟变构结合和小分子作用模式”的后续行动
- 批准号:
131071061 - 财政年份:2009
- 资助金额:
$ 4.16万 - 项目类别:
Research Grants
Effect of Thyrotropin-releasing hormone on gene expression in the islet of Langerhans of the pancreas
促甲状腺激素释放激素对胰岛朗格罕斯基因表达的影响
- 批准号:
21790887 - 财政年份:2009
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Young Scientists (B)